Crossmark

Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-024-07906-3

Published Online: 2024-01-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alhalabi, Marouf http://orcid.org/0000-0001-5027-2096
Almokdad, Rasha http://orcid.org/0000-0003-1637-7796
License Information

Text and Data Mining valid from 2024-01-15

Version of Record valid from 2024-01-15
More Information

Article History

Received: 7 October 2023

Accepted: 2 January 2024

First Online: 15 January 2024

Declarations

:

: Damascus Hospital Ethics Committee reviewed and approved this study (No: 41/23). Written informed consent to participate will be obtained from all participants.

: Not applicable. We have not included any individual’s data in our study protocol.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below